ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation
FRA:ABL • US0028241000
Current stock price
89.22 EUR
+0.19 (+0.21%)
Last:
This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABL.DE Profitability Analysis
1.1 Basic Checks
- ABL had positive earnings in the past year.
- In the past year ABL had a positive cash flow from operations.
- In the past 5 years ABL has always been profitable.
- Each year in the past 5 years ABL had a positive operating cash flow.
1.2 Ratios
- ABL has a better Return On Assets (7.52%) than 83.61% of its industry peers.
- ABL's Return On Equity of 12.51% is fine compared to the rest of the industry. ABL outperforms 78.69% of its industry peers.
- With a decent Return On Invested Capital value of 9.17%, ABL is doing good in the industry, outperforming 73.77% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for ABL is in line with the industry average of 10.18%.
- The 3 year average ROIC (8.63%) for ABL is below the current ROIC(9.17%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROIC | 9.17% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1.3 Margins
- ABL's Profit Margin of 14.72% is amongst the best of the industry. ABL outperforms 85.25% of its industry peers.
- In the last couple of years the Profit Margin of ABL has grown nicely.
- Looking at the Operating Margin, with a value of 18.85%, ABL is in the better half of the industry, outperforming 77.05% of the companies in the same industry.
- In the last couple of years the Operating Margin of ABL has grown nicely.
- ABL has a Gross Margin (56.68%) which is in line with its industry peers.
- ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% |
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
2. ABL.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABL is destroying value.
- ABL has more shares outstanding than it did 1 year ago.
- ABL has less shares outstanding than it did 5 years ago.
- ABL has a better debt/assets ratio than last year.
2.2 Solvency
- ABL has an Altman-Z score of 4.86. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 4.86, ABL belongs to the best of the industry, outperforming 81.97% of the companies in the same industry.
- ABL has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
- ABL has a better Debt to FCF ratio (1.75) than 80.33% of its industry peers.
- ABL has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
- ABL's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. ABL outperforms 70.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 4.86 |
ROIC/WACC0.89
WACC10.31%
2.3 Liquidity
- ABL has a Current Ratio of 1.58. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- ABL's Current ratio of 1.58 is in line compared to the rest of the industry. ABL outperforms 49.18% of its industry peers.
- ABL has a Quick Ratio of 1.18. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- ABL has a Quick ratio (1.18) which is comparable to the rest of the industry.
- The current and quick ratio evaluation for ABL is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 |
3. ABL.DE Growth Analysis
3.1 Past
- ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
- ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.67%.
- ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.38% yearly.
- The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ABL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 19.96 indicates a rather expensive valuation of ABL.
- Compared to the rest of the industry, the Price/Earnings ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 72.13% of the companies listed in the same industry.
- ABL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.60.
- The Price/Forward Earnings ratio is 17.90, which indicates a rather expensive current valuation of ABL.
- ABL's Price/Forward Earnings is on the same level as the industry average.
- ABL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.84, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.96 | ||
| Fwd PE | 17.9 |
4.2 Price Multiples
- ABL's Enterprise Value to EBITDA ratio is in line with the industry average.
- Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than 63.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.16 | ||
| EV/EBITDA | 15.89 |
4.3 Compensation for Growth
- ABL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.73
PEG (5Y)2.8
EPS Next 2Y10.76%
EPS Next 3Y10.34%
5. ABL.DE Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.42%, ABL has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 1.17, ABL pays a better dividend. On top of this ABL pays more dividend than 80.33% of the companies listed in the same industry.
- ABL's Dividend Yield is a higher than the S&P500 average which is at 1.90.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.42% |
5.2 History
- On average, the dividend of ABL grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
- ABL pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
- ABL's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ABL (4/2/2026, 7:00:00 PM)
89.22
+0.19 (+0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap155.03B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80.57
Price Target114.26 (28.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.42% |
Yearly Dividend2.06
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-8.26%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)-4.49%
EPS NY rev (1m)0%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.96 | ||
| Fwd PE | 17.9 | ||
| P/S | 4.03 | ||
| P/FCF | 24.16 | ||
| P/OCF | 18.68 | ||
| P/B | 3.43 | ||
| P/tB | 7.92 | ||
| EV/EBITDA | 15.89 |
EPS(TTM)4.47
EY5.01%
EPS(NY)4.98
Fwd EY5.59%
FCF(TTM)3.69
FCFY4.14%
OCF(TTM)4.78
OCFY5.35%
SpS22.13
BVpS26.03
TBVpS11.27
PEG (NY)1.73
PEG (5Y)2.8
Graham Number51.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROCE | 11.9% | ||
| ROIC | 9.17% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 20.3% | ||
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% | ||
| FCFM | 16.68% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 69.67% | ||
| Cap/Sales | 4.9% | ||
| Interest Coverage | 15.33 | ||
| Cash Conversion | 83.39% | ||
| Profit Quality | 113.35% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 4.86 |
F-Score6
WACC10.31%
ROIC/WACC0.89
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%
ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
How profitable is ABBOTT LABORATORIES (ABL.DE) stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.
What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?
The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 8 / 10.
Is the dividend of ABBOTT LABORATORIES sustainable?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 63.09%.